L'Oreal's Sales Rise After Boost From Europe, North America — Update
By Mauro Orru
L'Oreal posted higher sales for the first quarter, led by growth at its core consumer-products and dermatological-beauty divisions, particularly in Europe and North America.
The French cosmetics giant on Thursday reported sales of 11.24 billion euros ($12 billion) for the three months to the end of March, up 8.3% in reported terms and 9.4% on a like-for-like basis.
Sales in Europe climbed more than 12% in reported terms to EUR3.73 billion in what L'Oreal called a buoyant market, thanks to strong momentum for skincare, fragrances, and premium haircare products.
In North America, revenue increased almost 12% to EUR3.02 billion. The company said fragrances such as Born in Roma from Valentino and MYSLF from Yves Saint Laurent had fueled growth at its L'Oreal Luxe business, while the La Roche Posay and CeraVe skin care brands propelled sales at its dermatological-beauty division.
Sales in Latin America rose nearly 19%, though revenue in North Asia shrank 3.9%.
China has been a weak spot for L'Oreal for much of 2023, when the country's economy grew 5.2% compared with prepandemic rates of 6% or more. The country has been suffering from a prolonged downturn in the property sector as well as weak exports and consumer demand since it emerged from the Covid-19 pandemic.
Now, its economy seems to have picked up pace, with 5.3% growth in the first quarter. However, L'Oreal said the beauty market remained sluggish in mainland China.
Still, Chief Executive Nicolas Hieronimus said he is optimistic on the outlook of the global beauty market despite economic and geopolitical tensions. He expects L'Oreal will keep outperforming the market and achieve another year of growth in sales and profit.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
April 18, 2024 12:55 ET (16:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
10 Top-Performing Dividend Stocks
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters
-
CVS Earnings: Weak Medicare Advantage Profits Cut Into 2024 Outlook
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry